Andere talen Zentiva S.A.

Aandelen

slotkoers Bucharest S.E. Andere beurzen 00:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,38 ^RON	+1,20%		+6,29%	+15,75%

01/04	Biocon Limited, via Zentiva, ontvangt goedkeuring van (MHRA), U.K., voor haar complexe formulering Liraglutide (gSaxenda®) in 6mg/ml oplossing	CI
29/02	Zentiva S.A. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Biocon Limited, Through Zentiva, Receives Approval from, U.K., for its Complex Formulation Liraglutide (gSaxenda®) in 6mg/ml Solution	01/04
Biocon is the first generics company to obtain approval for diabetes drug, Liraglutide, in the U.K.	28/03
Zentiva S A : Convening notice Zentiva S.A. – OGMS and EGMS_29.04.2024	27/03
Zentiva S A : Memo_Substantiation note_OGMS_29.04.2024	27/03
Zentiva S A : Draft Resolution_OGMS_29.04.2024	27/03
Zentiva S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Zentiva S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	15/11
Zentiva S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	01-09-23
Zentiva S A : SCD_Zentiva_Fin report 30.06.2023-EN	31-08-23
Zentiva S A : SCD_Zentiva_Fin report 31.03.2023-EN	15-05-23
Zentiva S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
STEFFEN SALTOFTE APPOINTED AS CEO OF ZENTIVA	19-04-23
Zentiva S A : Memo_Substantiation note_OGMS_27.04.2023	27-03-23
Zentiva S A : Draft Resolution_OGMS_27.04.2023	27-03-23
Zentiva S A : Auditor’s Report_31.12.2022	27-03-23
Zentiva S A : Annual remuneration report for the management of Zentiva SA_2022	27-03-23
Zentiva S A : Remuneration policy for the management of Zentiva_draft	27-03-23
Zentiva S A : Memo_Substantiation note_EGMS_27.04.2023	27-03-23
Zentiva S A : Draft Resolution_EGMS_27.04.2023	27-03-23
Zentiva S A : SCD_Zentiva_Preliminary financial report_31.12.2022_EN	28-02-23

Geen resultaten voor deze zoekopdracht